Hyperlipoproteinemia Type Iib: Disease Bioinformatics
Research of Hyperlipoproteinemia Type Iib has been linked to Hypercholesterolemia, Hypercholesterolemia, Familial, Coronary Heart Disease, Atherosclerosis, Hyperlipoproteinemias. The study of Hyperlipoproteinemia Type Iib has been mentioned in research publications which can be found using our bioinformatics tool below. Researched pathways related to Hyperlipoproteinemia Type Iib include Transport, Pathogenesis, Secretion, Excretion, Platelet Aggregation. These pathways complement our catalog of research reagents for the study of Hyperlipoproteinemia Type Iib including antibodies and ELISA kits against LDLR, CFH, FH, APOB, APOLIPOPROTEIN B.
Hyperlipoproteinemia Type Iib Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Hyperlipoproteinemia Type Iib below!
For more information on how to use Laverne, please read the How to Guide.
We have 1841 products for the study of Hyperlipoproteinemia Type Iib that can be applied to Chromatin Immunoprecipitation, Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Hyperlipoproteinemia Type Iib is also known as Familial Combined Hyperlipoproteinemia, Familial Defective Apolipoprotein B-100, Hyperlipoproteinemia Type Ii, Hyperlipoproteinemia, Familial Combined, Type Iib Hyperlipoproteinaemia.